| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2025 | Nov 18, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 28.8 | -1,042 | -11.03% | ✓ | $18K |
| Aug 15, 2025 | Aug 19, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -59 | -1.12% | ✓ | $982.4 |
| May 15, 2025 | May 19, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -63 | -1.23% | ✓ | $458.6 |
| Feb 15, 2025 | Feb 19, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 42.5 | -3,338 | -3.31% | ✓ | $2.7K |
| Nov 15, 2024 | Nov 19, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 52.5 | -735 | -0.81% | ✓ | $397.6 |
| Oct 27, 2024 | Oct 29, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 42.5 | -2,983 | -3.26% | ✓ | $2.1K |
| Aug 15, 2024 | Aug 19, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 52.5 | -728 | -0.90% | ✓ | $611.5 |
| Aug 3, 2024 | Aug 6, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 18.8 | -24,480 | -23.85% | ✓ | $26.5K |
| May 15, 2024 | May 17, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 42.5 | -703 | -3.83% | ✓ | $660.8 |
| Feb 15, 2024 | Feb 16, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 25.0 | -3,374 | -17.68% | ✓ | $3.6K |
| Oct 27, 2023 | Oct 31, 2023 | Seres Therapeutics, Inc. | Officer | Sell | 15.0 | -2,907 | -25.59% | ✓ | $3.9K |